These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7213361)

  • 1. Estrogen regulation of specific messinger RNA's in human breast cancer cells.
    Adams DJ; Edwards DP; McGuire WL
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1354-61. PubMed ID: 7213361
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen induced synthesis of specific proteins in human breast cancer cells.
    Edwards DP; Adams DJ; Savage N; McGuire WL
    Biochem Biophys Res Commun; 1980 Apr; 93(3):804-12. PubMed ID: 7387677
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines.
    Westley B; May FE; Brown AM; Krust A; Chambon P; Lippman ME; Rochefort H
    J Biol Chem; 1984 Aug; 259(16):10030-5. PubMed ID: 6469952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.
    Horwitz KB; Aiginger P; Kuttenn F; McGuire WL
    Endocrinology; 1981 May; 108(5):1703-9. PubMed ID: 7194178
    [No Abstract]   [Full Text] [Related]  

  • 5. Dolichol-sugar derivative synthesis in human breast cancer cell line (T47D). Effects of estrogens and antiestrogens.
    Santa Cruz AR; Medrano EE; Baldi A
    Biochem Biophys Res Commun; 1985 Jan; 126(1):382-8. PubMed ID: 3970700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells.
    Strobl JS; Monaco ME; Lippman ME
    Endocrinology; 1980 Aug; 107(2):450-60. PubMed ID: 7389663
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.
    Valentin-Opran A; Eilon G; Saez S; Mundy GR
    J Clin Invest; 1985 Feb; 75(2):726-31. PubMed ID: 3855865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol induced proteins in the MCF7 human breast cancer cell line.
    Westley B; Rochefort H
    Biochem Biophys Res Commun; 1979 Sep; 90(2):410-6. PubMed ID: 508310
    [No Abstract]   [Full Text] [Related]  

  • 10. Human breast cancer: biologically active estrogen receptor in the absence of estrogen?
    Zava DT; Chamness GC; Horwitz KB; McGuire WL
    Science; 1977 May; 196(4290):663-4. PubMed ID: 193182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific protein synthesis regulated by estrogen in human breast cancer.
    Edwards DP; Adams DJ; McGuire WL
    J Steroid Biochem; 1981 Dec; 15():247-59. PubMed ID: 7339251
    [No Abstract]   [Full Text] [Related]  

  • 12. Nafoxidine-responsive uterine protein: further characterization and distinction from the "estrogen-induced" protein (IP).
    Mairesse N; Reiss N; Galand P; Kaye AM
    Mol Cell Endocrinol; 1981 Oct; 24(1):53-63. PubMed ID: 6173271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of estradiol-induced intranuclear inclusions by an anti-estrogen (nafoxidine) in mammotrophs of the Mongolian gerbil.
    Nickerson PA
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):29-30. PubMed ID: 1129319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division.
    Mukku VR; Kirkland JL; Hardy M; Stancel GM
    Endocrinology; 1981 Oct; 109(4):1005-10. PubMed ID: 7285857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of estrogen receptor binding and transcriptional activity in the stimulation of hyperestrogenism and nuclear bodies.
    Clark JH; Hardin JW; Padykula HA; Cardasis CA
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2781-4. PubMed ID: 275847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
    Gardner RM; Kirkland JL; Stancel GM
    Endocrinology; 1978 Nov; 103(5):1583-9. PubMed ID: 748005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different stability during incubation in vitro of the induced-protein (IP) response elicited in the rat uterus by treatment in vivo with oestradiol-17 beta or Nafoxidine [proceedings].
    Mairesse N; Galand P
    Arch Int Physiol Biochim; 1977 Dec; 85(5):1003-4. PubMed ID: 79342
    [No Abstract]   [Full Text] [Related]  

  • 18. RNA transcription and uterine growth: differential effects of estradiol, estriol, and nafoxidine on chromatin RNA initiation sites.
    Markaverich BM; Clark JH; Hardin JW
    Biochemistry; 1978 Jul; 17(15):3146-52. PubMed ID: 359041
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen action following irradiation of human breast cancer cells.
    Burke RE; Mira JG; Datta R; Zava DT; McGuire WL
    Cancer Res; 1978 Sep; 38(9):2813-7. PubMed ID: 679188
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogenic effects of nafoxidine on ovarian-dependent and independent mammary tumor lines in the mouse.
    Watson CS; Medina D; Clark JH
    Endocrinology; 1981 Feb; 108(2):668-72. PubMed ID: 7449742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.